IFNγ identified as crucial for reducing pulmonary viral loads in COVID-19, new research shows

The role of type-2 interferon (IFNγ) in antiviral immunity.

Deciding Who Is Dead: Physician Group Issues New Statement

A single word clarification is the only revision the Uniform Determination of Death Act (UDDA) needs, the American College of Physicians (ACP) stated. In a

September 6, 2023

SomaLogic, Standard BioTools to merge into $1B multi-omics tech provider

Proteomics biotech SomaLogic and biological research equipment company Standard BioTools are consolidating to become a multi-omics research tool provider. The all-stock merger is estimated to

October 5, 2023

Risk Adjusted Net Present Value: What is the current valuation of Compass Pathways’s CTX-471

The revenue for CTX-471 is expected to reach an annual total of $104 mn by 2040 globally based off GlobalData’s Expiry Model. The drug’s revenue

December 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.